The Securities and Exchange Commission (SEC) has expanded confidential submission privileges for Form S-1 filings, benefiting many life sciences companies. As of March 3, 2025, public companies, including those that became public through reverse mergers and those subject to “baby shelf” limitations, can now submit draft registration statements for confidential review.
Xuan Hong Tran
Specially Registered Attorney, Palo Alto
+1 650.849.5314
Xuan Hong Tran is a Specially Registered Attorney in the Palo Alto office of Gibson Dunn. Hong is a member of the Life Sciences Group.